Prostate Cancer

Prostate cancer is the most commonly diagnosed non-skin cancer in the United States and is the second leading cause of cancer death in men. The American Urological Association recommends men speak with their primary care providers or urologists to discuss their risk of prostate cancer. Based on family history, general health, age and other factors, a physician may recommend a prostate screening.


A prostate cancer diagnosis is confirmed by a biopsy. A pathologist studies the tissue samples from the prostate under a microscope to report the grade of the tumor. The grade tells how much the tumor tissue differs from normal prostate tissue and how fast the tumor is likely to grow. 

Grading Prostate Tumors

Tumors with higher grades tend to grow faster than those with lower grades. They are also more likely to spread. A patient and his doctor carefully evaluate both the effectiveness of the treatment options, as well as their side effects. Factors to consider include the stage, Gleason score, PSA level, patient’s age, any other diseases or conditions, potential side effects of treatments and personal preferences. 

Gleason Score

One system of grading is with the Gleason score. Gleason scores range from 2 to 10. The pathologist grades the tissue based upon the patterns of cells in the prostate tissue. The most common pattern is given a grade of 1 (most like normal cells) to 5 (most abnormal). The pathologist gives the second most common pattern a grade of 1 to 5, and adds the two most common grades together to make the Gleason score. A high Gleason score means a high-grade prostate tumor.

Stages of Prostate Cancer

Localized prostate cancer refers to cancer that is confined to the tissue in which it originated. This is stage I or stage II prostate cancer. Cancer at this stage has not spread to other organs. 

Advanced prostate cancer has spread outside of the prostate tissue. When prostate cancer spreads, it is often found in nearby lymph nodes. If cancer has reached these nodes, it may have spread to other lymph nodes and/or organs. Stage III and stage IV prostate cancer may be "locally advanced" (it has spread to areas surrounding the prostate) or metastatic (it has spread to other organs, frequently the bones). In addition, advanced cancer can refer to an earlier stage of prostate cancer that has come back after treatment.

Detecting the Spread of Prostate Cancer

When cancer spreads from its original place to another part of the body, the new tumor has the same kind of abnormal cells and the same name as the primary tumor. For example, if prostate cancer spreads to bones, the cancer cells in the bones are actually prostate cancer cells. The disease is metastatic prostate cancer, not bone cancer. For that reason, it is treated as prostate cancer, not bone cancer. Doctors call the new tumor “distant” or metastatic disease. 

The following tests may be used to determine if the cancer has spread and to what parts of the body:

Bone Scan

A small amount of a radioactive substance is injected into a blood vessel. It travels through the bloodstream and collects in the bones. A bone scan may show cancer that has spread to the bones. 

CT Scan

An X-ray machine linked to a computer takes a series of detailed pictures. Doctors use CT scans to look for prostate cancer that has spread to lymph nodes and other areas. The patient may receive contrast material by injection into a blood vessel in your arm or hand or by enema. 


A strong magnet linked to a computer is used to make detailed pictures of areas inside the body. An MRI can show whether cancer has spread to lymph nodes or other areas. Sometimes contrast material is used.